Scilex Holding SCLX
NASDAQ SCLX
$5.20 -0.17 (-3.17%)
At close: Sep 9, 2026 · 4:00 PM EDT

Scilex Holding (SCLX) Operating Income (2020 - 2026)

Scilex Holding (SCLX) posted Operating Income of -$29.4 million for Q2 2026, up 8.62% on a QoQ basis from -$32.2 million in Q1 2026, and down 43.48% year-over-year from -$52.1 million in Q2 2025.

Analysis

Scilex Holding (SCLX) Operating Income (2020 - 2026) Analysis & Trends

Scilex Holding has reported Operating Income for 7 years, with the latest figure at -$29.4 million in Q2 2026.

  • On a quarterly basis, Operating Income fell 43.48% year-over-year to -$29.4 million in Q2 2026; TTM through Jun 2026 was -$359.2 million, a 271.48% decrease from a year earlier, with the FY2025 full-year figure at -$346.0 million, down 314.9% from the prior year.
  • Operating Income was -$29.4 million for Q2 2026 at Scilex Holding, up from -$32.2 million in the prior quarter.
  • The five-year high for Operating Income was -$8.8 million in Q1 2022, with the low at -$186.5 million in Q3 2025.
  • Average Operating Income over 5 years is -$35.9 million, with a median of -$21.7 million recorded in 2023.
  • The sharpest annual moves came in 2022 and 2024: Operating Income sank 6563.76% in 2022, then surged 48.67% in 2024.
  • Over 5 years, Operating Income stood at -$19.7 million in 2022, then gained by 7.1% to -$18.3 million in 2023, then plunged by 54.74% to -$28.4 million in 2024, then tumbled by 291.47% to -$111.1 million in 2025, then soared by 73.51% to -$29.4 million in 2026.
  • The last three Operating Income figures came in at -$29.4 million (Q2 2026), -$32.2 million (Q1 2026), and -$111.1 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Op. Inc (Qtr)
1 Johnson & Johnson 643.26 Bn 622.50 Bn 17.26 Bn 7.14 Bn
2 AbbVie 443.31 Bn 436.74 Bn 12.70 Bn 6.43 Bn
3 Merck 364.74 Bn 357.60 Bn 12.21 Bn -584.00 Mn
4 Novartis Ag 266.46 Bn 258.77 Bn 11.24 Bn 4.75 Bn
5 Pfizer 158.57 Bn 146.88 Bn 10.94 Bn 4.27 Bn
6 Sanofi 52.33 Bn 44.95 Bn 10.79 Bn 1.22 Bn
7 Revolution Medicines 43.79 Bn 43.79 Bn - -505.13 Mn
8 Incyte 25.23 Bn 20.69 Bn 1.57 Bn 697.90 Mn
9 United Therapeutics 21.67 Bn 19.01 Bn 683.80 Mn 330.80 Mn
10 Scilex Holding 35.91 Mn -76.88 Mn 3.97 Mn -29.42 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -29.42 Mn
Mar 31, 2026 -32.20 Mn
Dec 31, 2025 -111.09 Mn
Sep 30, 2025 -186.51 Mn
Jun 30, 2025 -20.51 Mn
Mar 31, 2025 -27.90 Mn
Dec 31, 2024 -28.38 Mn
Sep 30, 2024 -19.92 Mn
Jun 30, 2024 -15.62 Mn
Mar 31, 2024 -19.48 Mn
Dec 31, 2023 -18.34 Mn
Sep 30, 2023 -38.81 Mn
Jun 30, 2023 -22.81 Mn
Mar 31, 2023 -25.47 Mn
Dec 31, 2022 -19.74 Mn
Sep 30, 2022 -10.62 Mn
Jun 30, 2022 -11.47 Mn
Mar 31, 2022 -8.81 Mn
Dec 31, 2021 -35.22 Mn
Sep 30, 2021 -283,346.00